Prehospital Pulse-dose Glucocorticoid in Patients With ST-segment Elevation Myocardial Infarction 2 - The PULSE-MI 2 Trial

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 5204 participants.

Also called NCT07478003

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 5,204 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07478003
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Denmark (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07478003. Randomized; quadruple masking; primary purpose treatment. Start 2026-04-20 (actual); primary completion 2031-04-20 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Prehospital Pulse-dose Glucocorticoid in Patients With ST-segment Elevation Myocardial Infarction 2 - The PULSE-MI 2 Trial
Acronym
PULSE-MI 2
Condition
STEMI - ST Elevation Myocardial Infarction
Intervention (Drug)
Methylprednisolone 250 mg
Intervention (Drug)
NaCl (0,9%)
Lead sponsor
Thomas Engstrom (class: other)
Collaborator
Aarhus University Hospital (class: other)
Collaborator
Odense University Hospital (class: other)
Collaborator
Aalborg University Hospital (class: other)
Collaborator
Prehospital Emergency Medical Service, The North Denmark Region (class: not stated)
Collaborator
Center for Prehospital and Emergency Research, Denmark (class: not stated)
Collaborator
Prehospital Center, Region Zealand (class: other)
Collaborator
Prehospital Emergency Medical Services Central Denmark Region (Præhospitalet) (class: not stated)

Record details

Record id
cardio:ct-nct07478003
Content hash
b5ce1d6f2fac1f7cd8ddb1e4cddfb2e372ec6694a8c78606c5e1286b0ca62720